Overview

Hayden Consulting Group provides strategy and analytics services to life sciences companies, focusing on market access, reimbursement, and commercialization in the US healthcare system. Its offerings include go-to-market strategy, new product planning, and patient services consulting, grounded in data analytics to inform decisions about stakeholder dynamics, coverage hurdles, and regulatory considerations. The firm differentiates itself through founders with deep experience at the intersection of commercial strategy and market access, a specialized focus on BioPharma market access within commercialization, and by joining BGB Group in 2026 to broaden planning, market access, communications, and launch execution under the Strategic Advisory practice. Hayden’s goal is to help clients ensure patient access to therapies by aligning market access with overall commercialization strategy and delivering actionable analyses that navigate payer obstacles and affordability concerns.

Simplify's Take

What believers are saying

• BGB acquisition expands addressable market by offering integrated solutions across entire brand lifecycle.
• Access to BGB's broader commercial solutions portfolio strengthens go-to-market and launch execution capabilities.
• Strategic Advisory practice leadership under Hilary Gentile enhances commercial due diligence and planning offerings.

What critics are saying

• Talent retention crisis: key employees may depart to boutiques or larger consulting firms post-acquisition.
• Integration execution failure could dilute market access expertise and cause client defection to specialized competitors.
• Larger consulting firms rapidly expanding life sciences practices with AI-driven reimbursement modeling directly compete.

What makes Hayden Consulting Group unique

• Integrates market access expertise with full-lifecycle strategic advisory, medical communications, and advertising services.
• Co-founders Sidore and MacDougall retain leadership, maintaining deep biopharma commercialization and market access experience.
• Resolves complex payer, reimbursement, and affordability obstacles using data-driven decision-making and strategic insights.

Help us improve and share your feedback! Did you find this helpful?

YesNo